營養基因組學市場 - 全球產業規模、佔有率、趨勢、競爭格局、機會及預測（按產品/服務、產品、技術、應用、地區和競爭情況分類），2021-2031年

全球營養基因組學市場預計將從 2025 年的 11.3 億美元成長到 2031 年的 21.2 億美元，複合年成長率為 11.06%。

營養基因體學是對營養與基因組之間相互作用的科學探索，分析基因變異對營養代謝的影響，以及反過來營養對基因表現的影響。該市場的成長主要受全球慢性文明病日益增多以及預防性和個人化醫療保健模式重大轉變的驅動。這種轉變源自於消費者對個人化健康策略而非一般建議的需求不斷成長。 2024年責任營養委員會（CRN）的一項調查顯示，69%的膳食補充劑使用者在選擇產品時優先考慮個人化攝取方案。

然而，由於複雜的法規環境和倫理挑戰，市場面臨許多障礙。缺乏全球統一的基因檢測指南，加上面向消費者的服務法規結構模糊不清，導致服務提供者營運面臨不確定性，也令醫療專業人員猶豫不決。此外，人們對隱私、安全以及敏感基因數據可能被濫用的嚴重擔憂，持續阻礙消費者廣泛接受這項技術。儘管市場需求強勁，但這些問題構成了主要阻礙，顯著延緩了營養基因組學評估融入標準臨床實踐的進程。

市場促進因素

慢性病和文明病的日益增加是全球營養基因組學市場的主要驅動力。隨著代謝紊亂和肥胖症在全球範圍內的發病率不斷上升，消費者正逐漸從一般的飲食指南轉向基於基因組的干涉措施，以期獲得更有針對性的疾病預防。這項轉變的根本原因在於，人們迫切需要透過精準的、基於基因資訊的飲食調整來管理非傳染性疾病，而不是被動地進行治療。為了強調這一緊迫性，世界肥胖聯盟於2024年3月發布的《2024年世界肥胖地圖集》預測，到2035年，全球肥胖成年人的數量將達到15.3億，這凸顯了營養基因組學策略所提供的預防性解決方案的重要性。

同時，人工智慧驅動的直接面對消費者的基因檢測的普及，正在使獲取複雜的基因組資訊變得更加大眾化。這些平台利用複雜的演算法將複雜的基因標記轉化為可操作的營養建議，繞過了傳統的臨床障礙，並直接與使用者互動。這種成長也體現在旨在擴展技術基礎設施的大量資本投資上。例如，Zoe在2024年8月的新聞稿中宣布，已獲得1,500萬美元的融資，用於擴展其人工智慧驅動的膳食評估平台。此外，價格親民的生物感測器技術正在擴大市場覆蓋範圍，顯著降低了個人化代謝追蹤的進入門檻，例如，雅培公司於2024年推出了售價49美元的Lingo連續血糖監測系統。

市場挑戰

監管和倫理環境是全球營養基因體學市場發展的主要障礙。缺乏標準化的全球指南導致市場環境分散，法律規範模糊不清，服務供應商面臨許多不不確定性。這種不確定性不僅阻礙了投資，也延緩了成熟臨床通訊協定的製定，並使醫療專業人員對採用營養基因組學評估猶豫不決。由於缺乏統一的合規機制，該市場難以從利基消費服務發展成為廣為接受的醫療解決方案。

此外，人們對敏感基因資料的隱私和安全問題深感擔憂，這嚴重削弱了消費者的信任。對數據濫用和潛在基因歧視的擔憂，是阻礙大規模應用的主要因素。日益增多的法律挑戰進一步加劇了這種動盪的商業環境。據國際隱私專業人士協會（IAPP）稱，2024年，該行業受到嚴格審查，僅伊利諾伊州《基因資訊隱私法》就引發了50多起申訴，凸顯了處理基因資訊時面臨的重大訴訟風險。因此，這些隱私和監管障礙共同抑制了消費者需求，阻礙了市場成長潛力。

市場趨勢

營養基因組學、微生物組分析和代謝體學的日益融合，正將市場關注點從靜態的遺傳標記轉向動態的多體學健康評估。這種綜合辦法將宿主遺傳數據與腸道微生物活性和代謝物結合，從而實現高度特異性的營養干預，既能解決生物學易感性問題，又能改善當前的功能性健康狀況。各公司正積極利用此趨勢，開發分析RNA定序和微生物基因表現的平台，以最佳化精準營養策略。例如，Viome在2024年9月的新聞稿中宣布，已獲得2,500萬美元的資金籌措，用於成立新的診斷部門，並將其人工智慧驅動的精準營養生態系統擴展到慢性病的檢測和管理領域。

同時，營養基因組學在運動領域的應用正在迅速擴展，運動員根據自身基因量身定做飲食，以最佳化恢復並降低受傷風險。精英團隊和運動營養師擴大使用專門的基因檢測組合來識別個體在咖啡因代謝、發炎反應和微量營養素吸收方面的差異，從而從試驗的方法轉向科學檢驗的通訊協定。該領域正在快速細分，檢測服務也不斷擴展以滿足高水準運動的需求。正如NutraIngredients.com網站2024年3月發表的題為《運動營養基因組學現狀》的報導中所述，Nutrigenomics公司的首席科學官證實，該公司目前的平台可以分析77個關鍵基因，從而為運動員的運動表現和恢復提供針對性的建議。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球營養基因體學市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品/服務分類（服務（營養基因體學基因檢測）、產品）
  • 依產品（維生素/補充劑、益生菌、益生元）
  • 依採集方法（唾液/口腔拭子、血液、其他）
  • 按應用領域（肥胖症、癌症研究、心血管疾病、消化系統健康、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美營養基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲營養基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區營養基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲營養基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲營養基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球營養基因體學市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Honeywell International Inc.
• Itron, Inc.
• Landis+Gyr AG
• Apator SA
• Diehl Stiftung & Co. KG
• Elster Group GmbH
• Xylem Inc.
• Schneider Electric SE
• Badger Meter, Inc.
• Zenner International GmbH & Co. KG

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Nutrigenomics Market is projected to expand from USD 1.13 Billion in 2025 to USD 2.12 Billion by 2031, registering a compound annual growth rate of 11.06%. Defined as the scientific exploration of interactions between nutrition and the genome, this field analyzes how genetic variations influence nutrient metabolism and conversely, how nutrients affect gene expression. The market is primarily propelled by the rising global prevalence of chronic lifestyle diseases and a significant transition toward preventative, personalized healthcare. This shift is fueled by growing consumer demand for tailored health strategies over generic advice, a sentiment echoed by the Council for Responsible Nutrition in 2024, which noted that 69% of supplement users prioritize personalized regimens when choosing products.

However, the market faces substantial hurdles due to a complex regulatory and ethical environment. The lack of standardized global guidelines for genetic testing, combined with ambiguous regulatory frameworks for direct-to-consumer services, creates operational uncertainty for providers and hesitation among medical professionals. Additionally, serious concerns regarding the privacy, security, and potential misuse of sensitive genetic data continue to impede widespread consumer adoption. These issues significantly delay the integration of nutrigenomic assessments into standard clinical practice, acting as a major restraint despite the strong demand drivers.

Market Driver

The escalating prevalence of chronic and lifestyle-related diseases serves as a primary engine for the Global Nutrigenomics Market. As rates of metabolic disorders and obesity rise worldwide, consumers are increasingly moving away from generic dietary guidelines in favor of genomic-based interventions that offer targeted disease prevention. This transition is supported by the critical need to manage non-communicable diseases through precise, gene-informed dietary adjustments rather than reactive medical treatments. Highlighting this urgency, the World Obesity Federation's 'World Obesity Atlas 2024', released in March 2024, projects that the number of adults living with obesity will reach 1.53 billion by 2035, underscoring the vital necessity for the preventive solutions provided by nutrigenomic strategies.

Simultaneously, the expansion of Direct-to-Consumer genetic testing, enhanced by artificial intelligence, is democratizing access to complex genomic insights. These platforms utilize sophisticated algorithms to convert intricate genetic markers into actionable nutritional advice, bypassing traditional clinical hurdles to engage users directly. This growth is reflected in significant capital investments aimed at scaling technological infrastructure. For example, Zoe announced in an August 2024 press release that it secured $15 million to expand its AI-driven dietary assessment platform. Furthermore, the market is broadening its reach through affordable biosensor technologies, such as Abbott's 2024 launch of the Lingo continuous glucose monitoring system at a $49 price point, which significantly lowers the barrier to entry for personalized metabolic tracking.

Market Challenge

The regulatory and ethical landscape constitutes a major obstacle for the Global Nutrigenomics Market. The absence of standardized global guidelines results in a fragmented environment where ambiguous regulatory frameworks create considerable uncertainty for service providers. This lack of clarity not only deters investment but also delays the development of established clinical protocols, causing medical professionals to hesitate in adopting nutrigenomic assessments. Without a unified compliance structure, the market struggles to evolve from niche direct-to-consumer offerings into widely accepted medical solutions.

Moreover, severe concerns regarding the privacy and security of sensitive genetic data significantly undermine consumer trust. Fears surrounding data misuse and potential genetic discrimination act as strong deterrents to mass adoption. This precarious operating environment is further evidenced by increasing legal challenges. According to the International Association of Privacy Professionals, the industry faced heightened scrutiny in 2024 with over 50 accumulated complaints filed under the Illinois Genetic Information Privacy Act, highlighting the substantial litigation risks involved in handling genetic information. Consequently, these privacy and regulatory barriers collectively stifle consumer demand and restrain the market's growth potential.

Market Trends

The integration of nutrigenomics with microbiome profiling and metabolomics is transforming the market, shifting the focus from static genetic markers to dynamic, multi-omic health assessments. This comprehensive approach combines host genetic data with gut microbial activity and metabolic outputs to enable highly specific nutritional interventions that address both biological predisposition and current functional health. Companies are actively capitalizing on this trend by developing platforms that analyze RNA sequencing and microbial gene expression to refine precision nutrition strategies. For instance, Viome announced in a September 2024 press release that it secured $25 million in funding to launch a new diagnostic division, aiming to extend its AI-driven precision nutrition ecosystem into chronic disease detection and management.

Concurrently, the application of nutrigenomics in the athletic performance sector is growing rapidly as sports professionals seek to optimize recovery and reduce injury risks through gene-based dietary tailoring. Elite teams and sports nutritionists are increasingly using specialized genetic panels to identify individual variations in caffeine metabolism, inflammation responses, and micronutrient absorption, replacing trial-and-error methods with scientifically validated protocols. This niche is professionalizing quickly, with testing services expanding their capabilities to meet high-performance demands. As noted in a March 2024 NutraIngredients.com article titled 'The state of science for genomics in sports nutrition', the Chief Science Officer of Nutrigenomix confirmed that their platform now analyzes 77 key genes to provide targeted recommendations for athletic performance and recovery.

Key Market Players

• Honeywell International Inc.
• Itron, Inc.
• Landis+Gyr AG
• Apator S.A.
• Diehl Stiftung & Co. KG
• Elster Group GmbH
• Xylem Inc.
• Schneider Electric SE
• Badger Meter, Inc.
• Zenner International GmbH & Co. KG

Report Scope

In this report, the Global Nutrigenomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nutrigenomics Market, By Product & Services

• Services (Nutrigenomics Genetic Testing)
• Product

Nutrigenomics Market, By Product

• Vitamins & Supplements
• Probiotics
• Prebiotics

Nutrigenomics Market, By Technique

• Saliva/Buccal Swab
• Blood
• Others

Nutrigenomics Market, By Application

• Obesity
• Cancer Research
• Cardiovascular Diseases
• Digestive Health
• Others

Nutrigenomics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nutrigenomics Market.

Available Customizations:

Global Nutrigenomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nutrigenomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Services (Nutrigenomics Genetic Testing), Product)
  • 5.2.2. By Product (Vitamins & Supplements, Probiotics, Prebiotics)
  • 5.2.3. By Technique (Saliva/Buccal Swab, Blood, Others)
  • 5.2.4. By Application (Obesity, Cancer Research, Cardiovascular Diseases, Digestive Health, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Nutrigenomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Product
  • 6.2.3. By Technique
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nutrigenomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technique
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Nutrigenomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technique
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Nutrigenomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technique
      • 6.3.3.2.4. By Application

7. Europe Nutrigenomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Product
  • 7.2.3. By Technique
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nutrigenomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technique
      • 7.3.1.2.4. By Application
  • 7.3.2. France Nutrigenomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technique
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Nutrigenomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technique
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Nutrigenomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technique
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Nutrigenomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technique
      • 7.3.5.2.4. By Application

8. Asia Pacific Nutrigenomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Product
  • 8.2.3. By Technique
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nutrigenomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technique
      • 8.3.1.2.4. By Application
  • 8.3.2. India Nutrigenomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technique
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Nutrigenomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technique
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Nutrigenomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Technique
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Nutrigenomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Technique
      • 8.3.5.2.4. By Application

9. Middle East & Africa Nutrigenomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Product
  • 9.2.3. By Technique
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nutrigenomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technique
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Nutrigenomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technique
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Nutrigenomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technique
      • 9.3.3.2.4. By Application

10. South America Nutrigenomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Product
  • 10.2.3. By Technique
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nutrigenomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technique
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Nutrigenomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technique
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Nutrigenomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technique
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nutrigenomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Honeywell International Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Itron, Inc.
• 15.3. Landis+Gyr AG
• 15.4. Apator S.A.
• 15.5. Diehl Stiftung & Co. KG
• 15.6. Elster Group GmbH
• 15.7. Xylem Inc.
• 15.8. Schneider Electric SE
• 15.9. Badger Meter, Inc.
• 15.10. Zenner International GmbH & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer